Home | List of Topics | Cancer | Urologic Cancer
Testicular cancer is cancer that starts in the testicles, the male sex glands located next to the penis.
Cancer - testes; Germ cell tumor; Seminoma testicular cancer; Nonseminoma testicular cancer
The exact cause of testicular cancer is unknown. However, several factors seem to increase a man's risk for the condition. They include:
Other factors under investigation as possible causes include exposure to certain chemicals and HIV infection. A family history of testicular cancer may also increase risk.
There is no link between vasectomy and testicular cancer.
Testicular cancer accounts for only 1% of all cancers in men in the U.S., but is the most common form of cancer in men age 15 - 40. In rare cases, it may occur at a younger age.
White men are five times more likely to develop this type of cancer than African Americans. White men are twice as likely as Asian-American men to have testicular cancer.
There are two main types of testicular cancer: Seminomas and nonseminomas. These cancers grow from germ cells, the cells that make sperm.
Seminoma: This is a slow-growing form of testicular cancer usually found in men in their 30s and 40s. The cancer is usually just in the testes. However, it can spread to the lymph nodes.
Nonseminoma: This more common type of testicular cancer tends to grow more quickly than seminomas. Nonseminoma tumors are often made up of different cell types, and are identified according to the cells in which they start to grow. Nonseminoma testicular cancers include:
A stromal tumor is a rare type of testicular tumor. Such tumors are usually not cancerous. The two main types of stromal tumors are Leydig cell tumors and Sertoli cell tumors. Leydig cells release the hormone testosterone, and Sertoli cells are where sperm matures. Stromal tumors may be seen during childhood.
Note: There may be no symptoms.
A physical examination typically reveals a firm lump (mass). When the health care provider holds a flashlight up to the scrotum, the light does not pass through the mass.
Other tests include:
Tissue biopsy is usually done by removing the testicle with surgery and then examining the tissue.
Treatment depends on the:
Most patients can be cured.
Once cancer is found, the first step is to determine the type of cancer cell by examining it under a microscope. The cells can be seminoma or nonseminoma. If both seminoma and nonseminoma cells are found in a single tumor, the tumor is treated as a nonseminoma.
The next step is to determine how far the cancer has spread to other parts of the body. This is called "staging."
Three types of treatment can be used.
Joining a support group where members share common experiences and problems can often help the stress of illness. Your local branch of the American Cancer Society may have a support group.
Lance Armstrong, a famous cyclist, is a survivor of testicular cancer. His web site -- www.laf.org -- offers support and information for patients with testicular cancer.
The National Cancer Institute also offers such information. Visit their website at www.cancer.gov.
Testicular cancer is one of the most treatable cancers.
The survival rate for men with early-stage seminoma (the least aggressive type of testicular cancer) is greater than 95%. The disease-free survival rate for Stage II and III cancers is slightly lower, depending on the size of the tumor and when treatment is begun.
Testicular cancer may spread to other parts of the body. The most common sites include the:
Complications of surgery can include:
If you are of childbearing age, ask your doctor about nerve-sparing surgery and methods to save your sperm for use at a later date.
Call your health care provider if you have symptoms of testicular cancer.
There is no known effective screening technique for testicular cancer. However, a testicular self-examination (TSE) performed on a monthly basis may help in detecting such cancer at an early stage, before it spreads. Finding it early is important to successful treatment and survival. Young men are often taught how to perform such exams shortly after puberty.
U.S. Preventive Services Task Force (USPSTF). Screening for testicular cancer: recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2004 Feb. 2 p.
Review Date:6/10/2008
Reviewed By:David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.